Fluocinonide

氟轻松

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFluocinonide
Drug Alias Name氟欣诺能TopsynVanosLidexNSC-101791
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPlaque psoriasisInflammationPsoriasis +[13
Global Approved IndicationsPsoriasisPruritusNeurodermatitis +[8
Approved Indications in ChinaPsoriasisPruritusNeurodermatitis +[7
Original Approved Country/TerritoryUnited States
Original Approved Date1971/06/30
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCounty Line Pharmaceuticals
China Registration ClassN/A

Develop Information

Active IndicationsPlaque psoriasisInflammationPsoriasis +[10
Inactive IndicationsDermatitisSkin DiseasesBreast Neoplasms

Other Information

ATC CodeC05AA11D07AC08